Concepedia

John R. Penrod

JR

59

Publications

3.3K

Citations

29

H-Index

1998

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Belgium)

McGill University

IQVIA (United Kingdom)

Bristol-Myers Squibb (Germany)

John R. Penrod is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

1998–2024

59

Publications

59

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee

Paul R. Fortin, John R. Penrod, Ann E. Clarke et al. · Arthritis & Rheumatism · 2002 · 430 citations

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Scott Antonia, Hossein Borghaei, Suresh S. Ramalingam et al. · The Lancet Oncology · 2019 · 361 citations · Full text

, , +5

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Martin Reck, Michael Schenker, Ki Hyeong Lee et al. · European Journal of Cancer · 2019 · 212 citations · Full text

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Motasim Badri, Gary Maartens, Sundhiya Mandalia et al. · PLoS Medicine · 2005 · 145 citations · Full text

Health services costs and their determinants in women with fibromyalgia.

John R. Penrod, Sasha Bernatsky, Viviane Adam et al. · PubMed · 2004 · 133 citations

Rows per page

1–5 of 59